Literature DB >> 24703342

Epidemiology of calcium pyrophosphate crystal arthritis and basic calcium phosphate crystal arthropathy.

Abhishek Abhishek1, Michael Doherty2.   

Abstract

Calcium pyrophosphate crystal deposition (CPPD) is common and mainly associates with increasing age and osteoarthritis (OA). Recent studies suggest that CPPD occurs as the result of a generalized articular predisposition and may also associate with low cortical bone mineral density. The epidemiology of basic calcium phosphate (BCP) crystal deposition is poorly understood. Although periarticular BCP crystal deposits occurs at all ages and in both sexes, intra-articular BCP crystal deposition tends to associate with increasing age and OA. Calcium pyrophosphate and BCP crystals frequently coexist in joints with OA.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Basic calcium phosphate crystal; Calcium pyrophosphate crystal; Calcium pyrophosphate crystal deposition; Epidemiology

Mesh:

Substances:

Year:  2014        PMID: 24703342     DOI: 10.1016/j.rdc.2014.01.002

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  12 in total

Review 1.  Clinical management of hypophosphatasia.

Authors:  Nick Bishop
Journal:  Clin Cases Miner Bone Metab       Date:  2015-10-26

2.  Comparison of outcomes after UKA in patients with and without chondrocalcinosis: a matched cohort study.

Authors:  V Kumar; H G Pandit; A D Liddle; W Borror; C Jenkins; S J Mellon; T W Hamilton; N Athanasou; C A F Dodd; D W Murray
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-03-19       Impact factor: 4.342

3.  High prevalence of chondrocalcinosis and frequent comorbidity with calcium pyrophosphate deposition disease in patients with seronegative rheumatoid arthritis.

Authors:  Martin Krekeler; Xenofon Baraliakos; Styliani Tsiami; Juergen Braun
Journal:  RMD Open       Date:  2022-06

4.  Proton-Pump Inhibitors and Risk of Calcium Pyrophosphate Deposition in a Population-Based Study.

Authors:  Jean W Liew; Christine Peloquin; Sara K Tedeschi; David T Felson; Yuqing Zhang; Hyon K Choi; Robert Terkeltaub; Tuhina Neogi
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-03-04       Impact factor: 5.178

Review 5.  Review: Unmet Needs and the Path Forward in Joint Disease Associated With Calcium Pyrophosphate Crystal Deposition.

Authors:  Abhishek Abhishek; Tuhina Neogi; Hyon Choi; Michael Doherty; Ann K Rosenthal; Robert Terkeltaub
Journal:  Arthritis Rheumatol       Date:  2018-06-14       Impact factor: 10.995

6.  Infective endocarditis initially manifesting as pseudogout.

Authors:  Tim Brotherton; Chad S Miller
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-03-09

7.  Disease-modifying effects of phosphocitrate and phosphocitrate-β-ethyl ester on partial meniscectomy-induced osteoarthritis.

Authors:  Yubo Sun; Nikkole Haines; Andrea Roberts; Michael Ruffolo; David R Mauerhan; Kim L Mihalko; Jane Ingram; Michael Cox; Edward N Hanley
Journal:  BMC Musculoskelet Disord       Date:  2015-09-30       Impact factor: 2.362

8.  Dual-energy CT collagen density mapping of wrist ligaments reveals tissue remodeling in CPPD patients: first results from a clinical cohort.

Authors:  Katharina Ziegeler; Sophia-Theresa Richter; Sandra Hermann; Kay Geert A Hermann; Bernd Hamm; Torsten Diekhoff
Journal:  Skeletal Radiol       Date:  2020-08-15       Impact factor: 2.199

Review 9.  The role of Interleukin-1 receptor antagonist as a treatment option in calcium pyrophosphate crystal deposition disease.

Authors:  Alberto Altomare; Addolorata Corrado; Nicola Maruotti; Daniela Cici; Francesco Paolo Cantatore
Journal:  Mol Biol Rep       Date:  2021-06-01       Impact factor: 2.316

10.  Recurrent Craniocervical Pseudogout: Indications for Surgical Resection, Surveillance Imaging, and Craniocervical Fixation.

Authors:  Amitoz Manhas; Prashant Kelkar; Joseph Keen; Steven Rostad; Johnny B Delashaw
Journal:  Cureus       Date:  2016-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.